1 min read
Date: January 17 -20, 2023
Location: Miami Beach Convention Center
Booth: 708
Event Website: https://advancedtherapiesweek.phacilitate.com/
Contact us to schedule a meeting at the show
Reach out directly to our experts attending the show
Join us for our live presentation!
Hear from Luca Alberici, the General Manager of our flagship cell and gene therapy production and manufacturing site in Milan. Luca is speaking at Advanced Therapies week on January 20th at 9:00 a.m. in the "Building Better Cell Therapy Processes" discussion panel. Join Luca and other academics and leaders from University of Pennsylvania, Pluri, CellPryme and more.
Click the link above to get all the details.
Learn about our cell and gene therapy services
Cell Therapy Production and Manufacturing
AGC Biologics’ cell therapy services support every stage of the product journey, from pre-clinical through commercialization. At our Milan and Longmont facilities, we can work with virtually any cell type – including Human Mesenchymal Stem Cells (hMSCs), Exosomes, CD34+, T-Cells, NK Cells, and more.
Using the latest autologous and allogeneic methods, we help your products meet the exact specifications for patients in a clinical or commercial setting.
Learn more about our overall cell therapy offering
Viral Vector Production and Manufacturing
AGC Biologics scientists have two decades of viral vector-based gene therapy expertise and specialize in adeno-associated viral vectors (AAV), lentiviral vectors (LVV), and retroviral vectors (RVV). Our sites in the U.S. and Italy have supported four commercial products.
Our ready-to-use platform capabilities for AAV and LVV programs are built on cell factories and bioreactors using adherent and suspension processes, designed entirely in-house.
Discover more about our viral vector services
Plasmid DNA (pDNA) Materials
To support your pDNA needs, AGC Biologics utilizes a customized process based on your specific plasmid and hosting system. We have extensive technical expertise in fermentation, purification, and analytics, and our highly experienced teams routinely manufacture GMP-grade pDNA materials. This work includes starting material for gene therapy, and viral vector manufacturing.
